AHAlMotsim Ben Hmeda

AlMotsim Ben Hmeda

*This is an algorithmically generated author record based on publicly available information.

AlMotsim Ben Hmeda has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Outcomes and complication rates of different materials used for nasal dorsal augmentation in septorhinoplasty: a systematic review and meta-analysis

    by Amr Gouda Shafik, Mohamed Naguib Mohamed, Ossama Mustafa Mady, Eman Soliman Fatallah, Gehad Mohamed Tawfik, Mona Hanafy Mahmoud, Esraa Mahmoud Mostafa, Ahmed M. Sayed, Phan Anh Vũ, Mahmoud Ali Alfadaly, et al.

    Autologous materials and alloplastic implants are commonly used in dorsal augmentation of septorhinoplasty (SRP). So far, there is no satisfactory evidence to ascertain the safest, efficient, and superior aesthetic outcomes among different materials. Objective This systematic review and meta-analysis (SR/MA) aim to compare the outcomes and complication rates of various materials used for nasal dorsal augmentation in SRP. Methods A comprehensive search was conducted in PubMed, Embase, and Cochrane Library databases. Studies were included based on predefined criteria, and data were extracted on outcomes and complications. Statistical analyses were performed to compare the materials. Thirteen electronic databases were searched from inception through December 2018 and a manual search in October 2019. Results A total of 280 eligible studies were included, of which 165 articles were included in MA. Alloplastic expanded polytetrafluoroethylene (e-PTFE) showed the highest graft scores across most outcomes with low complication rates. Silicone implants had a high success rate but slightly higher complications. Autologous materials such as bone and cartilage presented higher complication rates and donor site morbidity. Conclusion e-PTFE appears to be the superior material for nasal dorsal augmentation due to its high patient satisfaction and low complication rates. Future studies should focus on long-term outcomes and racial differences in material performance. Trial registration PROSPERO CRD42019119165.


  • Open Access

    Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis

    by Tran Quang Thach, Heba Gamal Eisa, AlMotsim Ben Hmeda, Hazem Faraj, Tieu Minh Thuan, Manal Mahmoud Abdelrahman, Mario Gerges Awadallah, Nam Xuan Ha, Michael Noeske, Jeza Muhamad Abdul Aziz, et al.

    Background: Predictive markers represent a solution for the proactive management of severe dengue. Despite the low mortality rate resulting from severe cases, dengue requires constant examination and round-the-clock nursing care due to the unpredictable progression of complications, posing a burden on clinical triage and material resources. Accordingly, identifying markers that allow for predicting disease prognosis from the initial diagnosis is needed. Given the improved pathogenesis understanding, myriad candidates have been proposed to be associated with severe dengue progression. Thus, we aim to review the relationship between the available biomarkers and severe dengue.Methodology: We performed a systematic review and meta-analysis to compare the differences in host data collected within 72 hours of fever onset amongst the different disease severity levels. We searched nine bibliographic databases without restrictive criteria of language and publication date. We assessed risk of bias and graded robustness of evidence using NHLBI quality assessments and GRADE, respectively. This study protocol is registered in PROSPERO (CRD42018104495).Principal findings: Of 4000 records found, 40 studies for qualitative synthesis, 19 for meta-analysis. We identified 108 host and viral markers collected within 72 hours of fever onset from 6160 laboratory-confirmed dengue cases, including hematopoietic parameters, biochemical substances, clinical symptoms, immune mediators, viral particles, and host genes. Overall, inconsistent case classifications explained substantial heterogeneity, and meta-analyses lacked statistical power. Still, moderate-certainty evidence indicated significantly lower platelet counts (SMD -0.65, 95% CI -0.97 to -0.32) and higher AST levels (SMD 0.87, 95% CI 0.36 to 1.38) in severe cases when compared to non-severe dengue during this time window.Conclusion: The findings suggest that alterations of platelet count and AST level—in the first 72 hours of fever onset—are independent markers predicting the development of severe dengue.